{"cdcTestId":"2013-0193","testcaseName":"Dose 1 to Dose 2 interval 6 mo-4 days.  Series complete.","vaccineGroup":"HepA","evaluationTestType":"Interval: At Absolute Minimum","forecastTestType":"Not recommended: series complete","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"2018-04-23T00:00:00","gender":"F"},"evaluation":{"seriesStatus":"Complete","administeredDoses":[{"dateAdministered":"2022-04-23T00:00:00","vaccineName":"Hep A, unspecified formulation","cvx":"85","mvx":"","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"Hep A, unspecified formulation","cvx":"85","mvx":"","evaluationStatus":"Valid","evaluationReason":null}]},"forecast":{"forecastNum":"-","earliestDate":"0001-01-01T00:00:00","recommendedDate":"0001-01-01T00:00:00","pastDueDate":"0001-01-01T00:00:00"},"doses":[{"dateAdministered":"2022-04-23T00:00:00","vaccineName":"Hep A, unspecified formulation","cvx":"85","mvx":"","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"Hep A, unspecified formulation","cvx":"85","mvx":"","evaluationStatus":"Valid","evaluationReason":null}],"dateAdded":"2013-01-01T00:00:00","dateUpdated":"2020-05-29T08:29:29.171","generalDescription":"This test case describes when the second dose of the HepA 2 dose vaccine is administered at 6 months - 4 days, that the dose is considered valid and the series is considered complete.","changedInVersion":"3.5","reasonForChange":"V3.5: Lowered Age from 8 years to 4 years to better associate with new Age Groupings. No Effective change to test case other than Age of patient and vaccinations."}